Hollings Cancer Center News

Drug combination shows promise in models of triple negative breast cancer

Yueying Liu and Dr. Antonio Giordano

Researchers report that a novel drug combination reduced tumor volume four-fold more than chemotherapy in an animal model of triple negative breast cancer.

Reducing health disparities focus of three new cancer research projects

Dr. Marvella Ford (right) and Dr. Judith Salley-Guydon

Hollings researchers have received funding from the NCI to support three new research projects under SC CADRE.

More Headlines


More News


News Center Headlines News Archives Publications Media Library For Journalists Press Releases Newsletters Subscribe

Back to top Back to top